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Integrating Facility-Based Surveillance With Healthcare
Utilization Surveys to Estimate Enteric Fever Incidence:
Methods and Challenges
Jason R. Andrews,1 Caitlin Barkume,2 Alexander T. Yu,1 Samir K. Saha,3 Farah N. Qamar,4 Denise Garrett,2 and Stephen P. Luby1
1Division of Infectious Diseases and Geographic Medicine, Stanford University, California; 2Typhoid Programs, Sabin Vaccine Institute, Washington, District of Columbia; 3Child
Health Research Foundation, Dhaka Shishu Hospital, Dhaka, Bangladesh; and 4Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan

Cohort studies and facility-based sentinel surveillance are common approaches to characterizing infectious disease burden, but present trade-offs; cohort studies are resource-intensive and may alter disease natural history, while sentinel surveillance underestimates
incidence in the population. Hybrid surveillance, whereby facility-based surveillance is paired with a community-based healthcare
utilization assessment, represents an alternative approach to generating population-based disease incidence estimates with moderate resource investments. Here, we discuss this method in the context of the Surveillance for Enteric Fever in Asia Project (SEAP)
study. We describe how data are collected and utilized to adjust enteric fever incidence for blood culture sensitivity, facility-based
enrollment, and healthcare seeking, incorporating uncertainty in these parameters in the uncertainty around incidence estimates.
We illustrate how selection of surveillance sites and their coverage may influence precision and bias, and we identify approaches in
the study design and analysis to minimize and control for these biases. Rigorously designed hybrid surveillance systems can be an
efficient approach to generating population-based incidence estimates for infectious diseases.
Keywords. typhoid; enteric fever; surveillance; incidence; methods; bias.
Enteric fever, an invasive infection with Salmonella Typhi or
Paratyphi, is estimated to be the cause of more than 15 million illnesses and 150 000 deaths annually, the vast majority
of which occur in low- and middle-income countries [1–3].
The World Health Organization recently prequalified a new
typhoid conjugate vaccine (TCV) and issued a recommendation that TCVs be utilized in the prevention of typhoid and
to be prioritized in countries with the highest burden of disease [4]. However, the majority of countries where typhoid is
believed to be endemic lack recent and geographically representative data on typhoid incidence. This may represent an
obstacle to introducing typhoid vaccines, including decision
making concerning which countries or subnational regions
to prioritize, as well as assessment of their impact on disease
burden.
The most rigorous form of infectious disease burden estimation is a prospective, community-based cohort study. This
form of study, commonly used for vaccine trials, involves
recruitment of healthy participants in the community who
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are followed closely for the development of incident typhoid
fever. Because individuals with typhoid often seek medical care
within days of symptom onset, studies often involve contacting each participant 2–3 times weekly to assess for the development of fever, followed by diagnostic testing for those who
report fever. As the incidence of typhoid is typically <1% per
year, typhoid cohort studies typically involve enrolling tens of
thousands of participants, which is costly and requires substantial research infrastructure [5–7]. Consequently, this approach
is relegated largely to short-term research studies and is not a
sustainable approach to disease surveillance. Additionally, by
actively contacting participants, diagnoses are typically made
early in the disease course, prompting therapy that averts
severe sequelae. This may alter the spectrum of disease toward
more mild cases, which may not be representative of the severity of illness that may be seen in the absence of surveillance.
For these reasons, cohort studies may be less attractive for
assessing vaccine effectiveness.
A more common surveillance approach is ascertainment of
cases presenting to healthcare facilities. This can be done retrospectively or prospectively, assessing culture positivity among
patients meeting a suspected case definition. This approach
requires fewer resources and, unlike cohort studies, may capture more severe cases as they are more likely to seek care. The
major drawback to this method is that it leads to substantial
underestimation of the population burden of disease, as only
a fraction of all typhoid patients seek care at hospital surveillance sites. Indeed, the majority of individuals with acute febrile

illness in typhoid-endemic countries seek care primarily at
pharmacies and medical shops, where blood culture capacity is
usually not available [8, 9].
There is therefore a gap between cohort studies, which
achieve direct population-level estimates of generally mild
infections and are resource intensive, and facility-based surveillance, which is inexpensive and underestimates incidence but
captures the more severe outcomes that are likely to motivate
interventions. A more recently developed approach between
these extremes involves pairing facility-based surveillance with
population-based healthcare utilization surveys, which we refer
to as “hybrid surveillance.” Hybrid surveillance, which has
been employed for a number of infectious diseases including
typhoid, enables the generation of population-based incidence
estimates with considerably fewer resource requirements than
cohort studies [10–12]. We have utilized hybrid surveillance
in phase 2 of the Surveillance of Enteric Fever in Asia Project
(SEAP), an ongoing study that aims to estimate typhoid incidence, clinical spectrum, outcomes, and costs in Bangladesh,
Pakistan, and Nepal.
While previous studies and a review have provided an overview of the methods for hybrid surveillance data collection and
analysis [10, 11, 13], they have not addressed how to incorporate uncertainty of various components or provided detailed
considerations for the design of reliable surveillance systems. In
this article, we describe methods used for hybrid surveillance,
including considerations concerning surveillance site selection,
sample size, and statistical approaches to incorporating uncertainty in various components of this model. We highlight key
assumptions underlying this approach and discuss difficulties
and potential for biases, as well as new methods for bias correction. The methods described here were developed in the context

of enteric fever surveillance, but may have broader applicability
to surveillance for other diseases.
HYBRID SURVEILLANCE FRAMEWORK AND
COMPONENTS

Hybrid surveillance may be thought of as characterizing the layers of a disease detection pyramid, where all typhoid patients
within a catchment area represent the base, and culture-confirmed cases detected at surveillance facilities represent the apex
(Figure 1). A fraction of all typhoid patients in the community
will seek care at study sites, a proportion of those are recruited
and enrolled into the surveillance system, and the sensitivity
of blood culture will determine how many cases are detected
among those enrolled. Hybrid surveillance involves adjusting
cases detected for these factors. Here, we describe the overall
surveillance approach, including how each of these parameters
is estimated, and then describe how these estimates are utilized
to generate incidence estimates.
First, the overall study population must be identified, usually in a geographically circumscribed area. It is possible to first
identify an area of interest, and then choose commonly utilized
healthcare facilities within that area to establish surveillance, but
often the surveillance sites with the capacity for microbiological
diagnoses are identified first and the catchment area is subsequently characterized. The catchment area of a health facility
generally depends on the disease of interest, with more severe
conditions having a larger catchment area for a well-resourced
facility; as a result, the catchment should area be defined with
respect to the disease that is being studied. Importantly, surveillance catchment areas are not drawn to identify the entire
geographic expanse of patients’ homes who utilize these facilities. Rather, catchments for surveillance are drawn by the
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Figure 1. Typhoid disease pyramid, where the base represents all typhoid patients in a catchment area and the apex represents culture-positive cases detected at study
sites. Culture sensitivity is estimated from the literature, enrollment capture is estimated at facilities, and facility coverage is estimated by a household survey. These factors
are utilized to adjust the crude incidence.
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surveillance team to optimize measurement of incidence. For
the SEAP phase 2 studies, the catchment areas were constructed
by mapping either suspected or culture-confirmed typhoid
cases from selected sentinel surveillance sites in recent years.
After mapping cases, geographical boundaries are identified
that contain the majority of cases and represent well-recognized
administrative boundaries (eg, city ward), enabling patients
presenting to facilities to easily identify whether they live within
the study catchment.
After the catchment area has been specified, healthcare utilization in that population is assessed by means of a household
survey. This is often done concomitantly with facility-based
surveillance. In the SEAP study, a multistage, cluster design
was utilized to select a representative subset of all households
in the catchment area for survey. The questionnaire focuses on
whether any individuals in the household met a simple, standardized definition for suspected enteric fever (fever ≥3 days)
within a time period in which recall is expected to be reliable
(past 8 weeks). As recall regarding hospitalization is thought to
be reliable for a longer recall period, additional questions are
asked about hospitalization within the past year for febrile illness. Questions concerning severity of the febrile illness, demographics, household assets, and water source are asked to enable
adjustments for differences in populations who seek care at the
study site and those who do not, as described below. This survey
may also be used to estimate the population size and age structure for the catchment area, if recent census data corresponding
to that area are not available.
Additionally and typically concomitantly, facility-based surveillance for enteric fever is established at one or more sentinel
sites within the catchment area. Patients seeking care at sentinel sites who meet study inclusion criteria are recruited and
offered enrollment into the study. For the SEAP study, enrollment criteria are as follows: an individual, residing within the
catchment area, who presents to the outpatient or emergency
department with fever for ≥3 consecutive days within the past
week. A blood culture is offered to all enrolled individuals, and
confirmed enteric cases are defined as individuals with a blood
culture positive for typhoidal Salmonella. Even under study conditions, not all individuals presenting to sentinel sites who meet
the enrollment criteria will be enrolled, due to missed cases (eg,
when research staff are not present), difficulties with collecting
blood, or declined consent. Logs are utilized to record the numbers of eligible patients who were not enrolled, to enable adjustment for this missing proportion. Systematic random sampling
(eg, enrolling every fifth eligible patient, or enrolling every
other day) may also be performed if resources are constrained,
though care must be taken to ensure that sampling remains systematic and selection biases are not introduced.
The final adjustment factor accounts for the sensitivity of the
diagnostic; for enteric fever, blood culture remains the primary
reference standard due to nearly perfect specificity and the lack
S270 • JID 2018:218 (Suppl 4) • Andrews et al

of highly specific alternative diagnostics [14]. Estimates for the
sensitivity of blood culture are derived from published literature, predominantly studies in which bone marrow culture (a
highly sensitive and specific approach, but unsuitable for largescale surveillance due to its invasive nature) was performed.
A recent meta-analysis reported a composite estimate of 61%
(95% confidence interval [CI], 52%–70%) [15]. Multiple factors
influence the sensitivity of blood culture including the duration
of fever prior to collection, recent antibiotic use, blood volume
collected, and the culture media, including use of antibiotic
binding resins. Ongoing work is aimed at characterizing the
influence of these parameters, which could enable better estimates for culture sensitivity according to these factors at each
study site.
ESTIMATING INCIDENCE FROM HYBRID
SURVEILLANCE

Crude incidence estimates from facility-based surveillance
are derived by dividing the total number of culture-confirmed enteric fever cases by the product of the population and
time:
Crude Incidence =

Cases
Population × Time

Adjusted incidence can be estimated by dividing the crude incidence by the 3 adjustment factors:
Adjusted Incidence =

Crude Incidence
A1 × A 2 × A 3

Here, A1 is the proportion of individuals in the community
meeting the case definition who seek care at the study site
(“facility coverage”), A2 is the proportion of patients presenting
to the facility and meeting the case definition who are enrolled
(“enrollment capture”), and A3 is the sensitivity of culture. In
some situations, partially adjusted incidence estimates, in which
not all factors are adjusted for, may be of interest. For example,
if there is concern about biases in healthcare utilization, estimates that adjust only for culture sensitivity and facility-based
enrollment may be desired, to provide a minimum estimate for
disease incidence. Estimates are often presented with stratification by age, using age-specific case counts, catchment population, and adjustors.
To characterize uncertainty in incidence while reflecting the
uncertainty in each of these adjustments, we perform Monte
Carlo sampling from distributions of cases (binomial) and
adjustment factors (beta). When population size is estimated
directly from the healthcare utilization survey, rather than census estimates, uncertainty in population size may be incorporated into the model.

FACILITY COVERAGE AND SAMPLE SIZE

The proportion of patients with enteric fever who seek care at
the surveillance sites (“facility coverage”) is a critical determinant of uncertainty in incidence estimates. Smaller facility coverage fractions require substantially larger healthcare utilization
surveys to achieve equivalent precision in incidence estimates.
To illustrate this, we simulate a hypothetical community with a
population of 500 000 and an annual enteric fever incidence of
2500 cases (500 per 100 000). We vary the proportion that present to surveillance sites (10%, 25%, 50%) and assume that care
seeking is binomially distributed. We compare precision of incidence estimates according to effective sample size (households
with a participant meeting the fever definition in past 8 weeks
and cluster adjusted sample) for each of these 3 facility-based
capture rates (Figure 2), ignoring uncertainty introduced by
culture sensitivity at this time.
For communities in which 50% of individuals with suspected
enteric fever seek care at the study sites, relative precision of
±10% (95% CI, 450–550 per 100 000) can be achieved by an
effective sample size of 550 households. By contrast, communities in which 25% and 10% of individuals seek care at study
sites would have errors of ±27% and 34%, respectively, at that
same sample size. Achieving ±10% error would require an effect
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Figure 2. Relative half-width of the 95% confidence interval (CI) achieved by
hybrid surveillance as a function of effect sample size (ie, number of households
with an individual meeting study definition for febrile illness) and fraction of
patients captured at study sites. Here, incidence is 500 per 100 000 and the population size is 500 000. A higher proportion of participants seeking care at the facility
improves the precision of the adjustment factor estimate as well as the precision
in the numerator, as more typhoid cases present to the facility. A larger healthcare
utilization sample size can improve precision in the adjustment factor estimate,
but greater uncertainty in the incidence estimate remains due to uncertainty in the
case number.

sample size of 2500 for communities with 25% seeking care at
study sites; this ±10% error rate would not be possible for communities with 10% seeking care at study site. The error does
not approach 0 because of the remaining uncertainty in the
numerator. For an equivalent population size, a lower proportion of individuals seeking care at the study site results in fewer
enrolled cases and a larger degree of uncertainty around crude
rates. In other words, lower facility coverage results in greater
uncertainty in both the numerator (cases, which are fewer when
this proportion is low) and the multiplier. A larger healthcare
utilization survey can offset the latter, but a longer study (to
enroll more cases) is required to offset the former.
ADDRESSING POTENTIAL BIASES

The hybrid surveillance pyramid has all typhoid patients as the
base, and the second level are those that seek care at the study
sites. The key multiplier here is the proportion of all typhoid
patients who seek care at the study sites; however, what is measured by the healthcare utilization survey is the proportion of
individuals meeting a typhoid suspect case definition (fever
≥3 days) who seek care at the study site. A fundamental assumption of this method has been that care-seeking patterns among
typhoid suspects provide an unbiased estimate for care seeking
among typhoid patients. If individuals with typhoid are more
(or less) likely to seek medical care, or to seek care at study sites,
than individuals with other febrile illnesses lasting 3 days, this
estimate may be biased. Bias in the estimate of this parameter
in turn leads to biased estimates of enteric fever incidence; specifically, if typhoid patients are more likely to seek care at study
sites than patients with other causes of fever, typhoid incidence
would be overestimated. The converse would also be true.
We hypothesized that individuals with typhoid may have
more severe symptoms than those with other febrile illnesses
(eg, viral infections) and therefore may be more likely to present
to tertiary facilities where surveillance is often conducted. In
the SEAP study, we therefore introduced two questions aimed
at assessing the severity of illness among individuals meeting
the suspected typhoid definition. First, we inquired about how
many hours the individual spent in bed on their worst day of illness. Second, we inquired about how many days the individual
was unable to conduct their usual activities due to illness. We
asked these questions in both the healthcare utilization survey,
as well as among culture-confirmed patients and culture-negative patients at the surveillance site. Additionally, we hypothesized that there may be associations between household wealth
and typhoid risk, as well as between wealth and healthcare seeking. For bias to occur, variables that are associated with typhoid
must also be associated with care seeking, and these associations must be conditionally independent.
Here, we present preliminary data from Nepal to illustrate
this process of assessing for biases. First, we compared the
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odds of seeking care and the odds of having culture-confirmed
typhoid, according to age, using generalized additive models.
We found strong and differential associations, which were nonlinear (Figure 3A). These findings clearly support the need for
age-stratified analyses to minimize biases with this method. We
found that both severity questions correlated positively with
both typhoid and care seeking at study site, indicating potential
bias in the estimate of this factor that would cause overestimation of incidence (Figure 3B). Conversely, we found that wealthier individuals were more likely to have typhoid, but less likely
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Figure 3. A, Log odds ratio for typhoid and care seeking, by age, in Surveillance
for Enteric Fever in Asia Project (SEAP) data from Nepal. The reference group is age
0. B, Log odds of typhoid and care seeking by demographic and severity indicators
in SEAP data from Nepal. Abbreviation: CI, confidence interval.
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to seek care at study sites, a potential bias that would lead to
underestimation of incidence.
To adjust for these potential biases, we perform a 2-stage
regression model, in which we first perform multivariable logistic regression to model the relationship between demographic
and severity factors and typhoid culture positivity using facility-based data. We then use this model to estimate typhoid culture positivity among febrile individuals in the catchment area
by utilizing the distribution of demographic and severity data
from the healthcare utilization survey. Dividing the observed
odds of typhoid from the facility data with the predicted odds
of typhoid in the healthcare utilization survey results in a summary odds ratio (OR) for typhoid among care seekers compared
with the general population. This OR can then be applied to the
adjusted incidence equation above to correct for differences in
care seeking.
In the preliminary Nepal data, we observed no statistically
significant differences in predicted typhoid prevalence between
those who sought care at study sites and those who did not
(P = .13), due to the offsetting effects of illness severity and
wealth. However, it should be noted that the absence of differences does not indicate that there are no differences, but rather
that the specified model did not identify them, which precludes
their adjustment in incidence estimates.
To illustrate the potential magnitude of this problem more
generally, we estimate the bias in incidence estimates as a function of (1) the OR of typhoid among individuals seeking care
compared with those not seeking care at study sites; (2) the proportion of the population seeking care at the study sites; and (3)
the proportion of care-seeking differences (ie, fraction of OR − 1)
that can be identified and adjusted for by the regression method
described above (Figure 4). We find that substantial bias (>70%)
may be seen when the OR for care seeking is high (>2), the proportion seeking care at study site is low (10%), and the proportion adjusted for is low (10%). By contrast, even with substantial
differences in care seeking (OR of 3), if 50% of the difference
can be adjusted for in the model and 50% of participants seek
care at the study site, the bias in incidence estimates would be
around 15%. These findings highlight the importance in establishing surveillance at sites with high coverage for febrile illness
in the catchment population and characterizing differences in
populations who seek care at study sites and those who do not.
An additional source of bias manifests when individuals,
meeting enrollment criteria for suspected typhoid, who are
enrolled at study sites differ from those who are not enrolled
with respect to typhoid risk. This may occur due to clinicians
or study staff preferentially enrolling individuals suspected to
have enteric fever or greater patient propensity to consent for
blood draw when they have more severe illness. In practice,
we have observed clinicians discouraging patient enrollment
in patients whom they believe are unlikely to have enteric
fever; however, we note that half of culture-confirmed cases
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Figure 4. Percentage bias in incidence estimate as a function of the odds ratio for care seeking at study facilities among typhoid patients compared with nontyphoid
patients, and the percentage adjusted for in the analysis. The proportion seeking care at the study site is 0.1 (A) and 0.5 (B).

occur in patients in whom the primary diagnosis was an
alternative infection. At some surveillance sites, clinicians
have reported not enrolling patients whom they are confident have enteric fever; the bias therefore may act in either
direction. The primary mechanism for addressing this
source of bias is through education of clinicians and study
staff about these data and encouraging consistent application
of suspected typhoid definitions. If enrollment rates are low
due to blood culture concerns by patients or clinicians, the
potential for bias is greater. In such settings, enrollment of
individuals who decline (or whose clinician advises against)
blood culture is useful to collect demographic and clinical
data along with clinician diagnoses. These data may be compared with data from enrolled participants with culture data

and can be used to generate regression-based estimates of
typhoid prevalence among individuals who do not have culture performed.
CONCLUSIONS AND FUTURE DIRECTIONS

Hybrid surveillance represents a lower-cost alternative to
cohort studies for generating population-based incidence
estimates for enteric fever and other infectious diseases. For
this reason, the ongoing SEAP and Severe Enteric Fever in
Africa (SETA) studies are utilizing this approach. Here, we
illustrated the framework, methods, and statistical considerations for estimating disease incidence and incorporating uncertainty in various components of the surveillance
pyramid. We identify several important considerations in
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hybrid surveillance design, implementation, and data analysis that have implications for the precision and accuracy of
estimates.
First, when the sentinel surveillance sites capture a lower proportion of typhoid cases, this results in lower precision around
typhoid incidence estimates, which may be only partially offset
by a larger healthcare utilization survey or longer study. Second,
we highlight a fundamental assumption in this surveillance
method, which is that individuals meeting a suspected typhoid
definition (fever ≥3 days) who present to surveillance sites
are representative of those who do not present to those sites,
with respect to their likelihood of having typhoid. In reality,
we might anticipate that individuals with typhoid, compared
with those with other illnesses, may have differences in illness
severity and sociodemographic factors that influence care-seeking patterns. These differences may lead to substantial bias in
incidence estimates, and the magnitude of this bias is inversely
proportionate to the proportion of patients who seek care at the
study site. When a smaller proportion of care-seeking individuals are used to infer risk about a larger proportion of individuals
not seeking care at the study site, the impact of small differences
is amplified.
We identify 3 potential approaches to minimizing this risk
of bias. The first is establishing surveillance sites that cover a
higher proportion of typhoid-like illnesses, which can be done
by either involving more sites or utilizing a smaller or more
carefully constructed catchment area, in which the care-seeking proportion is higher. Achieving higher coverage by sentinel
sites should reduce bias and improve precision of estimates. The
second is utilizing a more specific case definition for enrollment
at study sites and inference in the healthcare utilization survey.
For example, hybrid surveillance has been successfully performed for Japanese encephalitis by utilizing a suspected case
definition of fever with altered mental status or new-onset seizures, which are relatively uncommon and specific symptoms
for meningoencephalitis, and there is less likely to be differential care seeking according to type of encephalitis [13]. A key
challenge with typhoid is that the disease produces highly nonspecific manifestations that are variable and difficult to distinguish from other infections [16–18]. A recent study from Nepal
demonstrated that even clinician diagnoses have <10% positive
predictive value [19]. Attempting to select a more specific case
definition for typhoid (eg, ≥4 or 5 days, or absence of focal
symptoms) would reduce the number of eligible participants at
the surveillance sites and in the healthcare utilization survey,
offsetting efficiency gains, and could potentially introduce additional biases into the study design by focusing on a narrow set of
disease manifestations. The most tenable approach to addressing potential biases in care seeking may be in collecting data
to identify sociodemographic and severity factors that predict
typhoid risk and care seeking, which may enable adjustment as
outlined above.
S274 • JID 2018:218 (Suppl 4) • Andrews et al

Biases may also be introduced by selective enrollment at
the sentinel surveillance sites, if individuals with typhoid
are more likely to self-select for consent or be recruited
by clinicians or study staff. While it may be possible to
adjust for these biases by characterizing eligible nonenrolled patients, the best approach is to educate clinicians
and study staff about the poor predictive value of empirical
diagnoses, to maximize recruitment rates. If recruitment
remains low, the potential for bias is high, and obtaining
clinical data on eligible individuals who are not cultured
may be useful for comparison with that of individuals who
are cultured.
Due to the potential for biases in various components of
hybrid surveillance, it may be advisable to present multiple
estimates for disease incidence, highlighting the influence
of various assumptions (Figure 5). These include crude,
culture-confirmed incidence, incidence adjusted for culture sensitivity and facility-based enrollment, incidence
further adjusted for healthcare utilization, and, finally,
incidence adjusted for all of these factors along with bias
correction for differences in care seeking. We note that further adjustments may be possible and desirable, if the requisite data are available. For example, blood volume utilized
for culture and antibiotic use prior to blood culture likely
influence culture sensitivity; if this relationship is well
characterized and these data are available in the surveillance system, they may be used to further improve accuracy
of incidence estimates.
While case-based surveillance remains the only valid source
of data for typhoid burden assessment at present, we note that
seroepidemiologic approaches are under development. Most
of the experience to date has been with measuring immunoglobulin G to Vi antigen [20–22], which has been imperfect
and may increasingly be undermined as a marker of disease
burden due to the rollout of Vi-conjugate vaccines. Alternative
serologic markers have demonstrated promise for identifying
acute enteric fever and are being assessed for a potential role in
seroepidemiology [23, 24].
Hybrid surveillance is not without limitations, but for
relatively uncommon diseases (<1% per year), it represents
a powerful and efficient means for generating estimates of
disease incidence at a fraction of the cost of cohort studies.
With periodic healthcare utilization assessments alongside
continuous hospital surveillance, longitudinal monitoring
of trends in incidence of enteric fever may be maintained
in resource-limited settings, providing policy-relevant data,
including in the context of vaccine introduction. Careful
attention to potential sources of bias in system design,
implementation, and data analysis can improve the accuracy of incidence estimates and result in rigorous and sustainable systems for population-based infectious disease
surveillance.

1000

Adjustment Method
Crude
Culture + Enrollment
Culture + Enrollment + Care Seeking
Culture + Enrollment + Care Seeking + Bias

Incidence Estimate

750

500

250

0
0.1

0.25
Proportion Captured at Surveillance Site

0.5

Figure 5. Incidence estimates and uncertainty intervals according to adjustment method and proportion captured at the surveillance site. We assume 1 year of surveillance in a
population of 100 000 individuals with typhoid incidence of 500 per 100 000, a healthcare utilization assessment of 5000 households, and odds ratio of care seeking at study sites
for typhoid patients (bias) of 1.5. Culture sensitivity (assumed 59% [95% confidence interval, 54%–64%]); proportion of eligible individuals at study site enrolled (assumed 80%);
adjustment for care seeking (varied, x-axis); bias: adjustment for biases in healthcare seeking (correction of 67% of bias). The dashed line represents the true prevalence.
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